Naldebain

DRUG3 trials

Sponsors

Cathay General Hospital, China Medical University Hospital, Sinew Pharma Inc.

Conditions

Pain, PostoperativePostoperative Pain

Phase 2

A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management

Sinew Pharma Inc.Pain, Postoperative

Start: 2023-07-25End: 2024-12-31Target: 36Updated: 2023-07-27

Phase 4

Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy

CompletedNCT03713216

Cathay General HospitalPain, Postoperative

Start: 2018-07-01End: 2020-01-01Updated: 2020-07-16

NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis

China Medical University HospitalPostoperative Pain

Start: 2019-03-01End: 2019-10-31Target: 40Updated: 2019-02-26

Related Papers

<p>Preoperative Administration of Extended-Release Dinalbuphine Sebacate Compares with Morphine for Post-Laparoscopic Cholecystectomy Pain Management: A Randomized Study</p>

Journal of Pain Research2020-09-0121 citations